Synexus is a UK-based company that specializes in conducting clinical trials for pharmaceutical and biotech companies. It was founded in 1992 and has its headquarters in Manchester, United Kingdom. The main product and service offered by Synexus is its expertise in conducting clinical research studies.

The company runs clinical trials across various therapeutic areas, such as cardiovascular, endocrine, gastrointestinal, respiratory, and musculoskeletal disorders. These trials are held in purpose-built clinics that are equipped with state-of-the-art facilities. Synexus is known for its patient-centric approach, focusing on the well-being and satisfaction of the participants throughout the entire trial process.

Synexus has a global presence with clinics in Europe, the United States, Africa, and South America. In addition to its headquarters in the UK, the company has subsidiaries in Poland, Hungary, Bulgaria, South Africa, Chile, and Argentina. These international clinics allow Synexus to conduct trials in diverse patient populations and provide access to a larger pool of participants.

The company has formed partnerships and collaborations with various pharmaceutical and biotech companies, including major industry players. These partnerships enable Synexus to work on a wide range of clinical trials and access the latest investigational drugs and therapies. The company's strong relationships with these partners contribute to its market position and help it stay at the forefront of clinical research.

Synexus has witnessed significant growth and success since its inception. Over the years, the company has scaled its operations and expanded its global footprint. It has gained a favorable market position due to its strong track record in conducting successful clinical trials.

As of the latest update, Synexus continues to lead the field in clinical research and has recently been involved in groundbreaking studies. The company remains focused on providing high-quality patient care and contributing to medical advancements through its innovative approach to clinical research. Its commitment to excellence and patient well-being reinforces its position as a preferred partner for pharmaceutical and biotech companies seeking to conduct clinical trials